Rocky Mountain Cancer Centers is a clinical research site located in Parker, Colorado, United States 80138.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers has participated in 8 clinical trials.
Therapeutic areas: Metastatic Renal Cell Carcinoma, Early Breast Cancer, Tumors.
Sponsors: Pfizer, Eisai Inc., NovoCure Ltd..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers has 8 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Early Breast Cancer, Tumors.
Yes — Rocky Mountain Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.